DRMA
DRMA
NASDAQ · Biotechnology

Dermata Therapeutics Inc

$1.83
+0.06 (+3.39%)
As of Feb 8, 2:31 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.63M 2.53M 2.93M
Net Income 21.2K 20.0K 19.6K
EPS
Profit Margin 0.8% 0.8% 0.7%
Rev Growth -5.2% +23.9% +20.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 946.2K 972.0K 952.2K
Total Equity 3.56M 3.67M 3.72M
D/E Ratio 0.27 0.26 0.26
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 30.9K 30.5K 37.6K
Free Cash Flow 17.8K 22.0K 24.1K